EE552 Importance of Half Cycle Correction for Cost-Effectiveness Analysis: Case Study of Sacubitril/Valsartan Vs in Enalapril Heart Failure with Reduced Ejection Fraction
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.2530
https://www.valueinhealthjournal.com/article/S1098-3015(23)02720-1/fulltext
Title :
EE552 Importance of Half Cycle Correction for Cost-Effectiveness Analysis: Case Study of Sacubitril/Valsartan Vs in Enalapril Heart Failure with Reduced Ejection Fraction
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)02720-1&doi=10.1016/j.jval.2023.03.2530
First page :
Section Title :
Open access? :
No
Section Order :
10321